These distinguished cancer researchers
comprise our Advisory Board.
Dr. Malcolm Pike, Advisor
Keck School of Medicine, Univ. of Southern California
Malcolm Pike is the Flora L. Thornton Professor of Preventive Medicine at
Keck School of Medicine. He received his B.S. in Mathematics from
Witwatersrand University, South Africa, and his PhD in Mathematical
Statistics from Aberdeen University, UK.
Dr. Pike's main research interest is the chemoprevention of female cancers
by a hormonal contraceptive approach. He also has major interests in the
effects of hormone replacement therapy on breast and endometrial cancer, and
in the effects of diet on female cancer risk.
He has authored more than 350 scientific papers on various aspects of cancer
epidemiology and is a member of the Institute of Medicine of the National
Academies of Science.
His honors include the 1968 Guy Medal (Bronze) of Royal Statistical Society,
the 1994 Brinker International Award of the Susan G. Komen Breast Cancer
Foundation, and the 1996 USC Associates Award for Creativity in Research.
Dr. John Reed, Advisor
CEO, The Burnham Institute
John Reed earned his M.D. and Ph.D. from the University of Pennsylvania
School of Medicine in 1986, where he also received his clinical and
postdoctoral training. In 1989 He was appointed Assistant Professor,
Department of Pathology and Laboratory Medicine at University of
Pennsylvania School of Medicine, and Assistant Director, Laboratory of
Molecular Diagnosis at the Hospital of the University of Pennsylvania.
Dr. Reed was recruited to The Burnham Institute in 1992. He founded the
Institute's Program on Apoptosis and Cell Death Research and served as its
director until 2000. Dr. Reed served as the Institute's Scientific Director
from 1995 to 2001 and was appointed President and CEO on January 1, 2002.
He is the author of more than 450 scientific papers and has published more
articles on apoptosis and cell death in the past six years than any other
scientist worldwide. From 1996 to 1998,
Dr. Reed was ranked first among biomedical researchers worldwide for the
impact of his research. He is the recipient of numerous awards and honors,
and serves on the editorial boards of numerous scientific journals.
Dr. Dimitrios Trichopoulos, Advisor
Cancer Prevention, Harvard School of Public Health
Dimitrios Trichopoulos is the Vincent L. Gregory Professor of Cancer
Prevention and the former chair of the Department of Epidemiology at Harvard
School of Public Health. In addition to his position at Harvard, he is also a
professor at the University of Athens Medical School, where he received his
M.D. in 1963.
Over the past several decades Dr. Trichopoulos has made many pioneering
contributions to understanding the role of reproductive factors in the
etiology of breast cancer. His
main current research interest is the evaluation of the hypothesis that
steroid hormone-dependent cancers have their origin in the intrauterine
life, a theory that he expounded in a seminal paper in The Lancet
medical journal in 1990. This hypothesis is compatible with experimental
evidence and helps to explain why it takes more than two generations for the
incidence of breast and prostate cancer in Asian immigrants to the U.S. to
reach the four-times higher incidence prevailing in the host population.
Dr. Trichopoulos has also researched the significance of the traditional
Mediterranean diet in reducing the risks of cancer.
He has received many professional honors, including the prestigious Brinker
International Award in December 2000 from the Susan G. Komen Breast Cancer
Foundation for his research on factors contributing to the development of
Dr. Trichopolous is the author or co-author of more than 450 scientific
Richard G. Stevens, Co-Writer
Cancer Epidemiologist, University of Connecticut Health Center
Richard Stevens is a cancer epidemiologist who is well known in
the cancer research community. As a respected researcher who
speaks their language, he has access to top experts in each of
the scientific issues to be covered in the program. He
himself has also made widely cited scientific contributions to
understanding breast cancer.
Stevens has a B.S. in Genetics from the University of
California, Berkeley, and a Ph.D. in Epidemiology from the
University of Washington in Seattle. His working life has
been devoted trying to help figure out why people get cancer.
One of his major interests has been in the possible role of iron
overload. Largely on the basis of his work, published in
the Journal of National Cancer Institute and the New England
Journal of Medicine, the Swedish food industry decided to cease
iron fortification of flour in the early 1990s.
A perplexing challenge, which Stevens began to engage in the
late 1970s, is the confounding mystery of why breast cancer risk
rises so dramatically as societies industrialize. He
proposed in 1987 a radical new theory that use of electric
lighting, resulting in lighted nights, might produce “circadian
disruption” causing changes in the hormones relevant to breast
cancer risk. Accumulating evidence has generally supported the
idea, and it has received wide scientific and public attention.
For example, his work has been featured on the covers of the
popular weekly Science News (October 17, 1998) and the
scientific journal Cancer Research (July 15, 1996) as well as
cited in the October 16, 2000, cover story of US News & World
Report, “Sleepless in America” by Susan Brink, and the May 2001